There are no announcements yet.
Post-Traumatic Stress Disorder (commonly referred to by its acronym, PTSD) is a severe anxiety disorder that can develop after exposure to any event which results in psychological trauma. This event may involve the threat of death to oneself or to someone else, or to one's own or someone else's physical, sexual, or psychological integrity, overwhelming the individual's psychological defenses.
PTSD is a less frequent and more enduring consequence of psychological trauma than the more frequently seen acute stress response. PTSD has also been recognized in the past as railway spine, stress syndrome, shell shock, battle fatigue, traumatic war neurosis, or post-traumatic stress syndrome.
Diagnostic symptoms include re-experiencing original trauma(s), by means of flashbacks or nightmares; avoidance of stimuli associated with the trauma; and increased arousal, such as difficulty falling or staying asleep, anger, and hyper vigilance. Formal diagnostic criteria (both DSM-IV and ICD-9) require that the symptoms last more than one month and cause significant impairment in social, occupational, or other important areas of functioning (e.g. problems with work and/or relationships).
A study conducted at the Universitá di Firenze in Italy finds there is positive indications cannabis could help treat PTSD: "Consolidation refers to item stabilization in long-term memory. Retrieval renders a consolidated memory sensitive, and a "reconsolidation" process has been hypothesized to keep the original memory persistent. Some authors could not detect this phenomenon. Here we show that retrieved contextual fear memory is vulnerable to amnesic treatments and that the amygdala is critically involved. Cholinergic and histaminergic systems seem to modulate only consolidation, whereas cannabinoids are involved in both consolidation and reactivation. The liability of retrieved memory affords opportunities to treat disorders such as phobias, post-traumatic stress, or chronic pain, and these results help searching for appropriate therapeutic targets."
STC is regulated by the Securities and Exchange Commission
2901 N Dallas Parkway
Suite 380
Plano, Texas 75093
(469) 633-0101
FINAL Updated CSi – First Rights DATES !!!
*** March 31, 2021 is the Last Day for the CSi First Rights offering.
We need to begin the Cannabis...FINAL Updated CSi – First Rights DATES !!!
*** March 31, 2021 is the Last Day for the CSi First Rights offering.
We need to begin the Cannabis Science CSi share exchange with Omnicanna, so this is it.
As promised, we are reaching out to every email from every shareholder responding to the CSi- FR opportunity, Thanks for your patience. This extra time will allow us to do so. This will be the last extension as we need to begin the Cannabis Science share exchange and issue the first batch of the CSi – First Rights shares in ENDO immediately.
*** As planned, beginning March 1, 2021, we are now completing the paperwork and beginning to issue the first batch of CSi-First Rights ENDO shares right now.
If you have not already sent in your paperwork, please do now to be a part of this first group of share issuances. Otherwise, all the Best, we expect your Cannabis Science shares to do very well, as well !!!
We are booked solid though to mid-March at this point, if you book a call you will be included, so just book something before the end of March 2021 and you will be included.
We will announce the next update on this matter as we begin to issue this first batch of CSi-FR ENDO shares and make announcements for the first batch of CSi – ENDO share exchange shares right behind it.
Cheers!
Stay Safe and Strong.
Talk soon.
Raymond
Show more
Yeah, what is this shareholder gift? I didn’t receive anything and I called the transfer agency and they don’t know anything. Are our investments...
First.
If your shares are there still with your Broker or Transfer Agent, then you are good... Show more 10 minutes ago